APA (7th ed.) Citation

J, W., B, Y., L, B., H, Z., C, P., Y, Z., & H, T. (2025). Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer. Annals of surgical oncology, 32(7), 4890. https://doi.org/10.1245/s10434-025-17297-7

Chicago Style (17th ed.) Citation

J, Wang, Yang B, Bian L, Zhang H, Peng C, Zou Y, and Tang H. "Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer." Annals of Surgical Oncology 32, no. 7 (2025): 4890. https://doi.org/10.1245/s10434-025-17297-7.

MLA (9th ed.) Citation

J, Wang, et al. "Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer." Annals of Surgical Oncology, vol. 32, no. 7, 2025, p. 4890, https://doi.org/10.1245/s10434-025-17297-7.